street

5 Stock Trading Books for Beginners – StockBrain Blog

Books are one of many great resources that can teach you how to trade in the stock market. But let’s be honest, they may not be the best option, what with the introduction of the internet and instant access to blogs, forums and other communities. Books have kind of taken a back seat when it comes to teaching how to […]

Stock Market Bull Who Got 2014 Right Just … – Business Insider

Wikimedia CommonsComing into 2014, Oppenheimer’s John Stoltzfus was one of the most bullish voices on Wall Street, making him one of the most accurate strategists in this surprisingly strong year.For 2015, strategists are expecting stocks to move even higher, and again, no one is more bullish than Stoltzfus. “We have initiated a target for the S&P 500 at the end of 2015 […]

The Stock Market Bull Who Got 2014 Right Just … – Business Insider

Wikimedia CommonsComing into 2014, Oppenheimer’s John Stoltzfus was one of the most bullish voices on Wall Street, making him one of the most accurate strategists in this surprisingly strong year.For 2015, strategists are expecting stocks to move even higher, and again, no one is more bullish than Stoltzfus. “We have initiated a target for the S&P 500 at the end of 2015 […]

Stock Market News for December 09, 2014 – December 9, 2014 …

Benchmarks started the week on a dismal note after a slump in oil prices and disappointing overseas economic data dented investor sentiment. Energy shares were hit hard after oil prices plunged to a five-year low over continued concerns of oversupply. Moreover, discouraging China’s trade numbers, contraction of Japan’s economy and less-than-expected expansion in Germany’s industrial output has raised concerns of […]

The Most Bullish Chart You'll See Has A Big Stock Market Crash

More Charts

More and more Wall Street strategists* argue we should think about stocks as being in the middle phase of a long-term, multiyear, secular bull market.”Our view, which we have held since the market bottomed in 2009, is that the current bull market is secular, not cyclical,” Charles Schwab’s Liz Ann Sonders said. “Secular bull markets — like from 1949 […]

Stock Market News for December 05, 2014 – December 5, 2014 …

Benchmarks ended slightly lower on Thursday after hitting record highs on the previous day after the European Central Bank failed to provide solid clues about further monetary stimulus. Moreover, investors were also cautious ahead of Friday’s nonfarm employment report. However, encouraging jobless claims report limited some of the losses on Thursday.For a look at the issues currently facing the markets, […]

Don't try this: meet the high schooler who made $300K trading …

Share on FacebookShareSharePinShare
It was just a few weeks into the new school year when Connor Bruggemann decided to play sick. He holed up in his bedroom, shut the door, and opened his laptop. Over the summer his father had opened an Etrade account for him, using around $10,000 Bruggemann had saved up over two years working as a busboy and […]

Is Exelixis, Inc. Stock Doomed?

Biotech stocks are infamous for their volatile ways — shooting higher one minute, only to crater the next. After a biotech crashes, investors should always assess their options going forward. Sometimes a marked sell-off represents a compelling buying opportunity that can pay off handsomely over the long run. On the other hand, a mass shareholder exodus can trigger a series of events […]

BTIG's 2015 S&P 500 Forecast: 2,200 – Business Insider

BritneySpearsVEVO”I’m not a girl. Not yet a woman.” -Britney SpearsSee AlsoGOLDMAN: The Stock Market In 2015 Will Be … MehUBS On Stocks: ‘Roll Tide, Roll…’BAML: US Stocks Will Squeak Out A Tiny Gain In 2015BTIG’s Dan Greenhaus borrows from Britney Spears’ 2001 song “I’m Not a Girl, Not Yet a Woman” to express his feelings for the stock market.”With apologies […]

Solazyme is Trading Below Cash; Should You Buy?

When it comes to traditional biotech investing — that is, biotech stocks in healthcare — it’s not uncommon for a company to fall dramatically after a negative outcome from a binary event, such as a failed clinical trial. In some instances, development-stage companies with no products on the market and few revenue streams can see their market value fall below […]